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Abstract (139 words) 28 
Inflammasome-induced pyroptosis comprises a key cell-autonomous immune process 29 
against intracellular bacteria, namely the generation of dying cell structures. These so-30 
called pore-induced intracellular traps (PITs) entrap and weaken intracellular microbes. 31 
However, the immune importance of pyroptosis against extracellular pathogens remains 32 
unclear.  Here, we report that Type-3 secretion system (T3SS)-expressing Pseudomonas 33 
aeruginosa (P. aeruginosa) escaped PIT immunity by inducing a NLRC4 inflammasome-34 
dependent macrophage pyroptosis response in the extracellular environment. To the 35 
contrary, phagocytosis of Salmonella Typhimurium promoted NLRC4-dependent PIT 36 
formation and the subsequent bacterial caging. Remarkably, T3SS-deficient 37 
Pseudomonas were efficiently sequestered within PIT-dependent caging, which favored 38 
exposure to neutrophils. Conversely, both NLRC4 and caspase-11 deficient mice 39 
presented increased susceptibility to T3SS-deficient P. aeruginosa challenge, but not to 40 
T3SS-expressing P. aeruginosa. Overall, our results uncovered that P. aeruginosa uses its 41 
T3SS to overcome inflammasome-triggered pyroptosis, which is primarily effective against 42 
intracellular invaders. 43 
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Importance (119 words) 55 
Although innate immune components confer host protection against infections, the 56 
opportunistic bacterial pathogen Pseudomonas aeruginosa (P. aeruginosa) exploits the 57 
inflammatory reaction to thrive. Specifically the NLRC4 inflammasome, a crucial immune 58 
complex, triggers an Interleukin (IL)-1β and -18 deleterious host response to P. 59 
aeruginosa. Here, we provide evidence that, in addition to IL-1 cytokines, P. aeruginosa 60 
also exploits the NLRC4 inflammasome-induced pro-inflammatory cell death, namely 61 
pyroptosis, to avoid efficient uptake and killing by macrophages. Therefore, our study 62 
reveals that pyroptosis-driven immune effectiveness mainly depends on P. aeruginosa 63 
localization. This paves the way toward our comprehension of the mechanistic 64 
requirements for pyroptosis effectiveness upon microbial infections and may initiate 65 
targeted approaches in order to ameliorate the innate immune functions to infections.  66 
 67 
 68 
 69 
 70 
 71 
 72 
 73 
 74 
 75 
 76 
 77 
 78 
 79 
 80 
 81 
.CC-BY-NC-ND 4.0 International licensenot certified by peer review) is the author/funder. It is made available under a
The copyright holder for this preprint (which wasthis version posted May 28, 2019. . https://doi.org/10.1101/650333doi: bioRxiv preprint 
4 
 
Manuscript length (5621 words) 82 
Introduction  83 
Inflammasomes are pro-inflammatory cytosolic complexes whose activation leads 84 
to auto-processing of the protease caspase-1. Caspase-1 activation triggers the cleavage 85 
and release of the pro-inflammatory cytokines, interleukin (IL)-1β and IL-18 (1), as well as 86 
a pro-inflammatory form of cell death, called pyroptosis. Cleavage and activation of the 87 
pore forming effector gasdermin D (GSDMD) by caspase-1 or -11 can induce pyroptosis 88 
(2, 3). Several sensors contribute to inflammasome formation, including AIM2-like 89 
receptors (AIM2), PYRIN, and a subset of NOD-like receptors (NLRs), namely 90 
NLRP1/NLRP1B, NLRP3, NLRP6, NLRP7 and NLRC4, and the caspase-11-induced non-91 
canonical inflammasome pathway (1). 92 
Activation of the NLRC4 inflammasome follows an original path as it requires 93 
additional helper NLRs – the neuronal apoptosis inhibitory proteins (NAIPs) – that, upon 94 
ligand recognition, form hetero-oligomeric complexes with NLRC4 and promote its 95 
activation (4–10). Both NAIP5 and NAIP6 directly recognize cytosolic flagellin while NAIP-96 
1 and -2 detect the type-3 secretion system (T3SS) apparatus needle and rod subunits, 97 
respectively (1, 6). Importantly, resulting IL-1β and IL-18 cytokine secretion mediates 98 
intracellular bacterial clearance by inducing, respectively, phagocyte recruitment and the 99 
production of the microbicidal cytokine interferon (IFN)-γ (1, 6). A recently discovered and 100 
understudied cell-autonomous immune process known as pyroptosis promotes 101 
intracellular bacteria entrapment and weakening in pore-induced intracellular trap 102 
structures (PITs) (11–13), which facilitates subsequent bacterial elimination through 103 
efferocytosis (13–16). However, host-adapted bacteria can inhibit PITs formation, which 104 
enables bacterial proliferation (14).  105 
While NLRC4 activation confers protection to various pathogens, including 106 
Salmonella Typhimurium, Burkholderia pseudomallei and Legionella pneumophila (1, 6), it 107 
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also drives host susceptibility to the opportunist bacteria Pseudomonas aeruginosa (P. 108 
aeruginosa) (17, 18). In particular, P. aeruginosa T3SS and flagellin components induce 109 
NLRC4-mediated IL-1β and IL-18 secretion, which inhibits protection mediated by both 110 
Th17 cells and anti-microbial peptides produced by airway epithelial cells (17, 18). This 111 
apparent paradox underlies complex host-microbe interactions, as NLRC4 confers 112 
protection against other pathogens that express T3SS and flagellin. Here, we examined 113 
the underlying host-microbe mechanisms through which NLRC4 specifically drives 114 
susceptibility to P. aeruginosa. We used Salmonella enterica serovar Typhimurium 115 
(SL1344) and PAO1, a P. aeruginosa strain, that expresses a functional T3SS (T3SS+) in 116 
parallel with an isogenic mutant of this strain, inactivated in the T3SS transcriptional 117 
regulator exsA, unable to express a functional T3SS apparatus (T3SS-).  118 
 119 
Results 120 
Bacterial localization induces differential pyroptosis-dependent cell-autonomous 121 
response in macrophages. 122 
To decipher the molecular mechanisms underlying NLRC4-mediated sensing of the 123 
bacterial pathogen P. aeruginosa, we infected bone marrow-derived macrophages 124 
(BMDMs) from wild-type (WT) and Nlrc4–/– mice with either T3SS-expressing (T3SS+) P. 125 
aeruginosa and S. Typhimurium strains (19) and we measured the capacity of both strains 126 
to trigger NLRC4 inflammasome-dependent pyroptotic cell death and IL-1β release. In 127 
agreement with previous published reports, these data indicate that both bacteria triggered 128 
cell-death in a T3SS and NLRC4-dependent manner within 3 hours of infection (MOI 15) 129 
(Fig. 1A, Fig. S1A).  130 
While S. Typhimurium and P. aeruginosa have a different niche tropism (intracellular for 131 
Salmonella and extracellular for Pseudomonas), we hypothesized that the NLRC4 132 
response might lead to different bacterial fate in macrophages. Consequently, CFU assays 133 
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after 1 hour of infection (MOI 15) found more intracellular S. Typhimurium than P. 134 
aeruginosa in WT BMDMs (Fig. 1B). Strikingly, such differences in intracellular numbers of 135 
P. aeruginosa was partially lost in Nlrc4–/– macrophages and independent from P. 136 
aeruginosa T3SS-injected exoenzymes STY (Fig. 1B, Fig. S1B), suggesting that the 137 
NLRC4 inflammasome response contributed to P. aeruginosa avoiding macrophage 138 
uptake. Whereas Salmonella could efficiently establish an intracellular replicative niche in 139 
Nlrc4-/- BMDMs, intracellular P. aeruginosa failed to do so after 24 hours of infection (Fig. 140 
1C), which suggests that P. aeruginosa exploits NLRC4-dependent response to avoid 141 
macrophage intracellular-autonomous immunity. Phagocytosis is the main process by 142 
which macrophages engulf bacteria. Hence, inhibiting phagocytosis by cytochalasin D 143 
reduced NLRC4-dependent cell death and IL-1β release upon infection with S. 144 
Typhimurium but not with P. aeruginosa (Fig. 1D). Remarkably, T3SS+-induced 145 
phagocytosis-independent activation of the NLRC4 inflammasome was specific to only P. 146 
aeruginosa, as other T3SS-expressing bacteria triggered NLRC4 inflammasome 147 
responses in a phagocytosis-dependent manner (Fig. S1C). To rule out that actin 148 
polymerization might directly control NLRC4 activation, we electroporated purified flagellin 149 
in WT and Nlrc4-/- BMDMs in presence or absence of cytochalasin D. Cell death evaluation 150 
showed that cytochalasin D did not modify cytosolic flagellin-induced NLRC4 151 
inflammasome response (Fig. S1D). Thus, these results identified the unique capability of 152 
T3SS-expressing P. aeruginosa to promote NLRC4-inflammasome activation in a 153 
phagocytosis-independent manner.  154 
 “Pore-induced Intracellular Traps” (PITs) entrap intracellular S. Typhimurium (11–13). As 155 
P.aeruginosa induced phagocytosis-independent activation of the NLRC4 inflammasome, 156 
we reasoned that such process might be a virulence strategy to escape bacterial caging 157 
into PITs. Therefore, we infected primary WT BMDMs with both P. aeruginosa and S. 158 
Typhimurium strains (MOI 3) for 1h to induce PIT formation and evaluated the number of 159 
bacteria associated with pyroptotic structures (e.g. ASC+ cells). Strikingly, our results 160 
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found higher amount of Salmonella associated within PIT structures than P. aeruginosa, 161 
showing that P. aeruginosa-activated NLRC4 inflammasome allowed escape from PIT-162 
driven intracellular trapping (Fig. 1E, F).  163 
Then, we aimed to determine whether pyroptosis have a differential in vivo 164 
regulatory function after P. aeruginosa and S. Typhimurium exposure. Using a peritoneal 165 
mouse model of infection (3x106 CFUs, 6h) with either strains, we evaluated the 166 
contribution of pyroptosis on the early clearance of each bacterial strain in WT or in 167 
gasderminD-/- (gsdmD -/-) mice, which are deficient at inducing pyroptosis. Therefore, mice 168 
lacking gsdmD showed an early (6h) susceptibility to STm challenge whereas they 169 
presented improved resistance to P. aeruginosa infection (Fig. S1F). Overall, these results 170 
demonstrated that P. aeruginosa exploited the NLRC4 inflammasome to escape 171 
pyroptosis-mediated capture and sequestration, a process that was reversed in absence 172 
of Nlrc4. 173 
 174 
Pseudomonas triggers T3SS-independent NLRC4 and Caspase11 inflammasome 175 
activation in macrophages.  176 
Our results showed that both S. Typhimurium and P. aeruginosa-induced differential PIT-177 
dependent bacterial trapping. Yet, we wanted to rule out that the observed phenotype 178 
could be driven by intrinsic properties of each bacterial strain, such as flagellin and T3SS 179 
immunogenicity and/or expression levels.   180 
Therefore, we relied on a surprising observation where we found that infection of 181 
macrophages with a T3SS-deficient strain of P. aeruginosa still triggered early (3 hours) 182 
residual NLRC4 response and, late (4-10 hours) caspase11 non-canonical inflammasome 183 
pathway (Fig. 2A; Figs. S2A, B). Even though high doses (MOI 25, 50 or 100) of T3SS- P. 184 
aeruginosa were necessary to induce reduced levels of NLRC4 activation, residual 185 
inflammasome response was both still NLRC4- and -flagellin dependent, as T3SS-/fliC- 186 
strains failed to elicit measurable IL-1β release as well as caspase-1 and gasdermin-D 187 
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(GSDMD) processing (Figs. 2A, B; Fig. S2C). Furthermore, we noted that flagellin 188 
complementation in both T3SS+ and T3SS- strains restored NLRC4-driven cell death and 189 
IL-1β release (Figs. S2D, E). However, only live T3SS-deficient P. aeruginosa induced 190 
NLRC4-dependent IL-1β release as it was not detected using heat-killed (HK) and PFA-191 
killed bacteria (20) (Fig. S2F). To exclude that genetic inactivation of exsA allowed 192 
residual T3SS expression, we tested P. aeruginosa lacking PscC, a key T3SS structural 193 
component (21).  Importantly, pscC and exsA-deficient bacteria triggered comparable 194 
levels of NLRC4-dependent cell death and IL-1β release (Fig. S2G). These results 195 
indicate that activation of the NLRC4 inflammasome was not caused by residual T3SS 196 
expression.  197 
In the host, cytosolic NAIP proteins bind flagellin or T3SS components and initiate 198 
NLRC4 oligomerization (6). To confirm direct involvement of flagellin in NLRC4 activation, 199 
we infected macrophages lacking either Naip5 (Naip5–/–), the main flagellin sensor, or the 200 
5 different Naips (NaipΔ1-6), with either T3SS+ or T3SS- strain. Both Naip5–/– and NaipΔ1-6 201 
BMDMs failed to undergo pyroptosis and release IL-1β when infected with either strain 202 
(Fig. 2C). Based on these results, we conclude that flagellin directly triggered the NLRC4 203 
inflammasome response during T3SS- P. aeruginosa infection.  204 
Altogether, these findings reveal, in addition to the Caspase-11 non canonical 205 
inflamamsome, an unrecognized and unexpected capacity of P. aeruginosa to alternatively 206 
activate the NAIP5/NLRC4 inflammasome in a T3SS-independent yet flagellin-dependent 207 
manner. These findings further suggest that flagellin can reach the host cell cytosol 208 
independently of bacterial secretion systems. 209 
 210 
T3SS- P. aeruginosa-containing damaged phagosomes associate to sequential 211 
activation of NLRC4 inflammasome and Caspase-11.  212 
While our results indicated that flagellin and LPS reache the host cytosol in absence 213 
of a functional T3SS, the underlying mechanism still remained unknown. We hypothesized 214 
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that a key candidate involves direct entry of P. aeruginosa into the intracellular 215 
compartment. Therefore we evaluated whether T3SS-independent activation of both 216 
NAIP5/NLRC4 and Caspase-11 inflammasomes required P. aeruginosa phagocytosis. 217 
Consequently, infection of macrophages with T3SS- P. aeruginosa showed that 218 
phagocytosis inhibition abrogated cell death, IL-1β release and Caspase-1 processing 219 
(Fig. 3A-C). Hence, these results show that, in absence of a functional T3SS, P. 220 
aeruginosa induces inflammasome response in a phagocytosis-dependent manner. As 221 
phagocytosis of T3SS-deficient P. aeruginosa is a prerequisite for inflammasome 222 
response, we hypothesized that NAIP5/NLRC4 and Caspase11 responses required that 223 
both flagellin and LPS reached the cytosol by leaking from P. aeruginosa-containing 224 
phagosomes. To visualize phagosomal membrane alterations, we probed for galectin-3 225 
(GAL3), a lectin that binds galactosides on permeabilized host cell endovesicles (22). If P. 226 
aeruginosa-containing phagosomes were compromised, we expected GAL3 recruitment 227 
around bacteria. To avoid unwanted GAL3 recruitment to permeabilized phagosomes from 228 
pyroptosis and not P. aeruginosa specifically, we infected immortalized Casp1–/–/11–/– 229 
macrophages with two T3SS mutants (e.g. T3SS- and T3SS-/fliC-) for 3 hours. Confocal 230 
microscopy revealed that GAL3 did target a small proportion (~ 6-10%) of intracellular 231 
T3SS- and T3SS-/fliC- bacteria (Fig. 3D). We then reasoned that cells with active 232 
inflammasomes, i.e. containing ASC specks, should also contain at least one GAL3-233 
positive bacterium. Using macrophages expressing an active inflammasome (ASC 234 
specks+), we quantified the percentage of cells that had at least one GAL3- positive P. 235 
aeruginosa. We consistently found that approximatively 45% of iCasp-1–/–/11–/– 236 
macrophages presenting an ASC speck were also positive for GAL3-stained T3SS- P. 237 
aeruginosa (Figs. 3D, E), but we did not detect any specks using T3SS-/fliC- strain (Fig. 238 
3E). Casp1–/–/11–/– deficient BMDMs can form a NLRC4 inflammasome that recruit 239 
caspase-8 that also triggers cell death. To verify that in Casp1–/–/11–/– iBMDMs, GAL3 240 
recruitment to intracellular bacteria did not require caspase-8, we removed Nlrc4 in GAL3-241 
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mcherry expressing Casp1–/–/11–/– iBMDMs (Fig. S3A) and quantified GAL3 recruitment to 242 
T3SS- P. aeruginosa. We did not detect any defect for bacteria targeted by GAL3-243 
mecherry in the Nlrc4-/-/Casp1–/–/11–/– iBMDMs, hence confirming that T3SS- P. 244 
aeruginosa is targeted by GAL3 independently of the NLRC4-dependent pathway (Fig. 245 
S3B). Overall, these results show that T3SS- P. aeruginosa trigger NLRC4 inflammasome 246 
from altered phagosomes. 247 
Given that T3SS- P. aeruginosa were exposed to the cytosol, we speculated that 248 
phagosome alterations could also expose P. aeruginosa LPS to the host cell cytosol, 249 
which might promote caspase11 recruitment and activation. Thurston et al. showed that 250 
caspase11 was recruited to cytosolic Salmonella in infected epithelial cells (25). So, we 251 
sought to determine whether caspase11 associated with compromised P. aeruginosa-252 
containing phagosomes. Microscopy observations of galectin-3+ (GAL3+) bacteria in IFNγ-253 
primed Nlrc4–/– iBMDMs showed recruitment of both GAL3 and active caspase on T3SS- 254 
P. aeruginosa after 3 hours of infection, which was not observed in Nlrc4–/–/Casp11–/– 255 
CRISPR-Cas9 iBMDMs (Fig. 3F). These results confirm that bacteria accessible to the cell 256 
cytosol directly recruited caspase-11.  257 
Altogether, these results indicate that both NLRC4 and Caspase11 directly detected 258 
intracellular T3SS- P. aeruginosa flagellin and LPS from compromised phagosomes.  259 
 260 
Pyroptosis-induced PITs is efficient only against T3SS-deficient Pseudomonas.  261 
As we previously showed that T3SS-expressing P. aeruginosa and S. Typhimurium 262 
triggered differential PIT responses in macrophages, we evaluated whether pyroptosis-263 
induced PITs also promoted restriction of intracellular P. aeruginosa. Primary WT BMDMs 264 
were infected with T3SS+ or T3SS- for 3 h to induce PIT formation. Time-lapse microscopy 265 
revealed that cells with compromised plasma membranes (e.g. positive for the DNA 266 
impermeant binding probe TO-PRO-3) contained a high number of intracellular T3SS- P. 267 
aeruginosa, while few T3SS+ P. aeruginosa were associated with dead cells (Movie 1 that 268 
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refers to T3SS+ PAO1-infected cells, Movie 2 that refers to T3SS-PAO1-infected 269 
cells). In addition, confocal microscopy experiments showed that PITs (i.e. ASC+ cells) 270 
were enriched specifically with T3SS- bacteria (Fig. 4A, B). Based on these results, we 271 
conclude that T3SS-expressing P. aeruginosa hijacked PIT-mediated intracellular bacterial 272 
entrapment and weakening, a process reversed in the absence of T3SS expression.  273 
The capability of PITs to entrap mostly T3SS-deficient bacteria suggested that 274 
these structures might also have a direct or an indirect microbicidal function against these 275 
strains, as suggested by S. Typhimurium infection (13, 15). We then infected primary WT 276 
BMDMs with either T3SS+ or T3SS- P. aeruginosa for 3h and monitored the microbicidal 277 
potential of PITs. PITs-associated or –unbound bacteria were harvested and exposed to 278 
purified neutrophils or PBS for 1h30. We quantified CFUs, which showed that PITs-279 
associated bacteria specifically were more susceptible to neutrophil killing than the PITs-280 
unbound fraction (Fig. 4C). Since phagocytosis of both T3SS+ and T3SS- P. aeruginosa 281 
was comparable in Nlrc4 deficient BMDMs (Fig. 4D), we hypothesized that pyroptosis 282 
induction in these cells would weaken both bacteria to the same extent. We infected Nlrc4-283 
/- BMDMs with both T3SS+ and T3SS- P. aeruginosa strains and subjected them to ATP 284 
stimulation to ensure similar NLRP3 inflammasome-dependent pyroptosis induction in both 285 
conditions. Intracellular bacteria were harvested, counted and exposed to a secondary 286 
stress signal (i.e. H2O2). Both intracellular P. aeruginosa strains showed the same 287 
increased susceptibility to H2O2 (Fig. 4E), thus demonstrating that PIT-driven intracellular 288 
trapping was only efficient against T3SS-deficient P. aeruginosa. Finally, we performed a 289 
peritoneal mouse model of infection (3x106 CFUs, 4h) with GFP-expressing T3SS+ or 290 
T3SS- P. aeruginosa, and evaluated bacteria-containing dead macrophages efferocytosis 291 
by neutrophils (13). Strickingly, recruited neutrophils (Ly6G+) having efferocytosed 292 
bacteria-containing macrophages (Ly6G+/F4/80+/GFP+) was more efficient against T3SS- 293 
P. aeruginosa than to T3SS+ bacteria (Fig. 4E; Fig. S4A). Overall, these results 294 
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demonstrated that P. aeruginosa used its T3SS to escape PIT-mediated capture and 295 
sequestration. This process was reversed in absence of T3SS-expression or of Nlrc4. 296 
 297 
Both NLRC4 and Caspase-11 specifically protect against acute infection with T3SS-298 
deficient P. aeruginosa. 299 
To evaluate the in vivo relevance of our findings, we infected WT and Nlrc4–/– mice 300 
with either T3SS+ or T3SS- P. aeruginosa. Because T3SS- P. aeruginosa is highly 301 
susceptible to immune defenses (23), we infected mice with a higher dose of this strain. 302 
When infected for 18h with T3SS+ P. aeruginosa, Nlrc4–/– mice presented lowered 303 
bacterial loads in the bronchoalveolar lavage fluid (BALF) than their WT counterparts (Fig. 304 
5A), consistent with a prior report (18). Remarkably, Nlrc4–/– mice infected with the T3SS- 305 
strain showed an increased BALF bacterial loads compared to WT controls after 18h of 306 
infection (Fig. 5A). The use of T3SS-/fliC- P. aeruginosa did not show any involvement of 307 
NLRC4 on bacterial loads in BALFs, confirming that flagellin was the principal component 308 
that mediates in vivo NLRC4 response to T3SS-deficient P. aeruginosa (Fig. S5A). 309 
While strongly reduced, the residual IL-1β levels found in BALFs of mice infected 310 
with the T3SS-deficient P. aeruginosa strain remained partially dependent on the NLRC4 311 
inflammasome (Fig. 5B), whereas infection with T3SS-/fliC- bacteria showed no NLRC4-312 
dependent IL-1β release (Fig. S5B). Since we previously showed that caspase-11 could 313 
also detect intracellular P. aeruginosa, we speculated about the potential immune 314 
importance of this pathway in vivo. Although Casp11 deficient mice did not show 315 
significant involvement of caspase-11 at controlling the T3SS+ strain, T3SS- and T3SS-316 
/fliC- bacterial infection induced a higher susceptibility in these mice than their WT 317 
counterparts (Figs. 5C, D; Figs. S5C, SD). This result verified that both NLRC4 and 318 
caspase-11 play paired protective roles only against T3SS-deficient P. aeruginosa.  319 
After airway infection, P. aeruginosa will encounter alveolar macrophages as the 320 
first phagocytic cells. So, we evaluated the importance of alveolar macrophages on 321 
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inflammasome-triggered differential host responses to P. aeruginosa. Mice infected with 322 
T3SS+ and T3SS- P. aeruginosa showed that alveolar phagocyte depletion (Fig. 5E) 323 
increased alveolar loads of T3SS- P. aeruginosa (Fig. S5E) and strongly impaired IL-1β 324 
release in the alveoli (Fig. 5F). These results demonstrated that alveolar macrophages 325 
controlled inflammasome-mediated immune responses to P. aeruginosa in mice. 326 
Overall, these results demonstrate that T3SS-expressing P. aeruginosa exploited 327 
the NLRC4-dependent response to their own advantage, but T3SS deficiency uncovered 328 
host protective NLRC4- and caspase-11 responses. 329 
 330 
Discussion 331 
Although the NAIP-NLRC4 inflammasome primarily controls intracellularly adapted 332 
bacteria Salmonella or Legionella spp, several studies indicate the critical function of the 333 
T3SS-flagellin complex in mediating NLRC4-dependent host susceptibility to P. 334 
aeruginosa infection is still discussed (17, 18, 24)(25). Regarding P. aeruginosa infection, 335 
the deleterious functions of both IL-1β and IL-18 on immune control of T3SS-expressing P. 336 
aeruginosa infection is well documented (18, 26), yet the role of pyroptosis in this process 337 
remains unclear. 338 
Here, we provide evidence that NLRC4-dependent pyroptosis of macrophages drive 339 
differential outcomes of T3SS-expressing P. aeruginosa and S. Typhimurium. Whereas S. 340 
Typhimurium remains entrapped into PITs, as previously demonstrated (13, 16), P. 341 
aeruginosa-induced extracellular activation of the NLRC4 inflammasome allows bacterial 342 
escape from macrophage and pyroptosis-driven cell-autonomous immunity. To our 343 
knowledge, such response is unique to P. aeruginosa, as other T3SS-expressing bacteria 344 
also required uptake to activate the NLRC4 inflammasome. A recent study found that P. 345 
aeruginosa T3SS triggered a Caspase-3/-7 deleterious host response in an ASC-346 
dependent manner (27). Therefore, it is tempting to speculate that a similar mechanism 347 
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underlying T3SS-expressing P. aeruginosa-induced cell apoptosis could also mediate 348 
bacterial escape from host immune responses. 349 
In addition, we uncovered that a T3SS-deficient strain of P. aeruginosa also 350 
triggered residual, but of immune importance, NAIP5/NLRC4 inflammasome, in a T3SS-351 
independent manner, which is in agreement with findings of Faure et al., where lethal 352 
challenge of T3SS-deficient P. aeruginosa still induce a NLRC4-dependent response  in 353 
mice. In addition, T3SS-expressing P. aeruginosa triggered inflammasome assembly 354 
through a process that did not heavily utilize phagocytosis (28–30). We do not believe that 355 
the presence of a genetically encoded phagosomal permeabilization system in P. 356 
aeruginosa is likely, as only a minority (~6-10%) of bacteria were accessible to cytosolic 357 
galectin-3. Another explanation could involve phagosome maturation-induced P. 358 
aeruginosa local production of outer-membrane vesicles (OMVs), which could expose 359 
bacterial ligands to host cell cytosol sensors (31–34). Conversely, Nlrc4 deficiency or long-360 
term infection of macrophages promoted a switch in the NLRC4 response to a LPS-361 
induced caspase-11 non-canonical inflammasome path. Although previous results from 362 
others and our group indicated that OMVs from P. aeruginosa induced non-canonical 363 
inflammasome pathway in a phagocytosis-independent, yet endocytosis-dependent 364 
manner, our results here demonstrated that T3SS-deficient P. aeruginosa-triggered 365 
caspase-11 non-canonical inflammasome responses required bacterial uptake (31–34). 366 
Future investigations will be critical to determine the specific roles of OMVs and 367 
intracellular P. aeruginosa for nucleation of the non-canonical inflammasome route. 368 
Immunodeficiency, burn-, nosocomial- and ventilator-associated injuries render patients 369 
susceptible to chronic P. aeruginosa infection, in which most strains are deficient for T3SS 370 
and/or flagellin expression (35, 36). A recent report suggested that T3SS- P. aeruginosa 371 
promoted the non-canonical inflammasome pathway in an IFN- and GBP-dependent 372 
manner (37). Consistent with these data, we also showed that caspase-11 protected mice 373 
from acute infection with lethal doses of T3SS-deficient P. aeruginosa.  374 
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The in vivo function of NLRC4 to P. aeruginosa infection remains unresolved as it 375 
can be either protective or deleterious to the host in mouse models (24, 38). Our mouse 376 
model of acute infection revealed a deleterious role of NLRC4 on host defenses during 377 
exposure to T3SS-expressing P. aeruginosa (17, 18). Importantly, we demonstrated that 378 
P. aeruginosa T3SS deficiency induced both NLRC4- and caspase-11-driven host 379 
protection during infection. Attree’s group analyzed isolated naturally T3SS deficient 380 
clinical isolates from patients (39). Some strains expressed flagellin and were motile (40). 381 
These findings warrant investigating whether these bacteria also induce a NLRC4 382 
dependent response.  383 
Overall, our study uncovered that T3SS-expressing P. aeruginosa remained 384 
extracellular by triggering cell pyroptosis, a process that enabled bacteria to overwhelm 385 
macrophage PITs-induced host immunity. We further demonstrated that phagocytosis of 386 
P. aeruginosa that lacked T3SS expression triggered host protective pyroptosis in a T3SS-387 
dependent manner through both NLRC4 and caspase-11 inflammasomes. In summary, we 388 
propose that bacterial localization drives the effectiveness of the inflammasome response 389 
during bacterial infection (Graphical abstract). Future studies will determine if this is a 390 
conserved response among bacterial pathogens.  391 
 392 
 393 
 394 
 395 
 396 
 397 
 398 
 399 
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Methods 400 
All reagents and biological samples used in this study are listed in the table S1 401 
Mice  402 
Casp11–/–, Casp1–/–/Casp11–/–, Nlrc4–/–, Nlrp3–/– and Gsdmd–/– mice have been 403 
previously described (41–43). Mice were bred in the animal facilities of the University of 404 
Basel (Basel, Switzerland) or at the IPBS institute (Toulouse, France). Bones from Naip5–/– 405 
and NaipΔ1-6 mice were a kind gift from R. E Vance (UC Berkeley, USA) (43). Janvier and 406 
Charles Rivers companies provided WT mice. 407 
 408 
Animal infections 409 
6-8 age and sex-matched animals (8–10 weeks old) per group were infected 410 
intranasally with 5x106 (PAO1 T3SS+) or 1.5x107 (PAO1 T3SS- or T3SS-/fliC-) CFUs of 411 
mid-late exponential phase Pseudomonas aeruginosa in 40µl PBS. Animals were 412 
sacrificed 18h after infection and bronchoalveolar fluids (BALFs) were collected in PBS. 413 
When specified, cellular contents (flow cytometry), bacterial loads (serial dilutions and 414 
CFU plating) and cytokine levels (ELISA) were evaluated. No randomization or blinding 415 
were done.  416 
 417 
Clodronate-induced alveolar phagocyte depletion 418 
C57BL/6 mice received intranasal instillation of 40µL of either clodronate or PBS 419 
loaded liposomes to deplete alveolar macrophages (18). 48 h later, mice were intranasally 420 
infected with either 5x106 (PAO1 T3SS+) or 1.5x107 (PAO1 T3SS-) CFUs of mid-late 421 
exponential phase Pseudomonas aeruginosa (OD of 1.0-1.6) in 40µl PBS. 18 h after 422 
infection, BALFs were collected and bacterial loads (serial dilutions and CFU plating), 423 
cytokine levels (ELISA) and immune cell contents were evaluated. Briefly, cells were 424 
pelleted (1000 rpm, 5 minutes) and alveolar macrophages were subsequently stained with 425 
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a cocktail of fluorochrome-conjugated antibodies detailed in the material section. Cells 426 
were then fixed in 4% PFA before fluorescence associated cell sorting (FACS) analysis 427 
using a LSRII instrument (BD Biosciences). Data analysis and processing were performed 428 
using FlowJo.10 software. The plot FSC-A vs FSC-H was used to discriminate doublets 429 
from single cells. Alveolar macrophages were defined as CD11c+/F480+ in Ly6C-/Ly6G-430 
/CD19-/TCRβ- population. 431 
 432 
Genetic invalidation of Nlrc4 and Caspase11 genes in iCasp1–/–/Casp11–/– and iNlrc4–433 
/– immortalized BMDMs  434 
Nlrc4 was knocked-out using the crispr/cas9 system in iCasp1-/-/Casp11-/- macrophages 435 
and Casp11 was knocked-out from iNlrc4-/- macrophages. Single guide RNAs (sgRNA) 436 
specifically targeting Nlrc4 exon3 (Forward: 5’CACCGTTACTGTGAGCCCTTGGAGC3’ 437 
reverse: 5’AAACGCTCCAAGGGCTCACAGTAA-C3’) and Caspase-11 exon 2 forward 438 
(5‘CACCGCTTAAGGTGTTGGAACAGCT3’) reverse 439 
(5’AAACAGCTGTTCCAACACCTTAAGC3’) were designed using Benchling tool 440 
(Benchling.com), and oligonucleotides were synthesized by Sigma-Aldrich. The gene-441 
specific crispr guide RNA oligonucleotides were hybridized and cloned in Lenti-gRNA-442 
Puromycin vector using BsmBI restriction sites (lentiGuide-Puro, Addgene 52963, from 443 
Feng Zhang lab). These constructs were transfected (using lipofectamine 2000) into 444 
HEK293T cells together with the lentiviral packaging vector p8.91 (from Didier Trono lab, 445 
EPFL, Switzerland) and a envelop VSVg-encoding vector (pMD.2G, Addgene 12259, from 446 
Didier Trono lab) for 48 h. Then, viral supernatants were harvested, filtered on 0.45 µm 447 
filter. Cas9-expressing recipient-cells either iCasp1–/–/Casp11–/– or iNlrc4–/– (1,000,000 448 
cells/well in 6-well plates) were generated by lentiviral transduction with Cas9-expressing 449 
lentiviral vector (lentiCas9-Blast, Addgene 52962, from Feng Zhang lab) and then infected 450 
with the lenti-Guide viral particles in presence of 8μg/ml polybrene and centrifugated for 2 451 
h at 2900 rpm at 32°C. 48 h later, medium was replaced and Puromycin selection 452 
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(10µg/mL) was applied to select positive clones for two weeks.  Puromycin-resistant cells 453 
were sorted at the single cell level by FACS (Aria cell sorter). Individual clones were 454 
subjected to western blotting to confirm the absence of either Nlrc4 or Caspase-11 gene 455 
products. To ensure clonal reproducibility, at least 2 positive clones were compared for 456 
inflammasome response. 457 
 458 
Cloning and cell transduction 459 
Galectin-3-morange construct was a kind gift from J. Enninga (Institut Pasteur, 460 
Paris, France). Galectin-3-morange coding sequence was sub-cloned into the pMSCV2.2 461 
plasmid by first excising EGFP at the EcoRI sites followed by insertion using NotI/XhoI 462 
sites. Immortalized WT, Nlrc4–/–, Casp1–/–/Casp11–/– or Nlrc4–/–/Casp11–/– BMDMs were 463 
then transduced with retroviral particles, positive cells for morange fluorescence were 464 
FACS to allow clonal selection. 465 
 466 
Cell culture and infections.  467 
Bone-marrow derived macrophages (BMDMs) were differentiated in DMEM 468 
(Invitrogen) with 10% v/v FCS (Thermo Fisher Scientific), 10% MCSF (L929 cell 469 
supernatant), 10 mM HEPES (Invitrogen), and nonessential amino acids (Invitrogen). 470 
BMDMs were seeded in 6-, 24-, or 96-well-plates at a density of 1.25x106, 2.5x105, or 471 
5x104 per well. When required BMDMs were pre-stimulated overnight with 100ng/mL of 472 
PAM3CSK4 (InvivoGen). For infections with Pseudomonas strains, bacteria were grown 473 
overnight in Luria Broth (LB) at 37 °C with aeration. Bacterial cultures were diluted 1/50 474 
and grew until mid-late exponential phase (OD of 1.0-1.6) and added to the macrophages 475 
at multiplicity of infection (MOI) of 25, 50 and 100, in serum and antibiotic-free medium 476 
(OPTIMEM), or as otherwise indicated. Then, to ensure homogenous infections, plates 477 
were centrifuged for 1 minute, 800 rpm. 1 h after infection, extracellular bacteria were 478 
killed by adding gentamicin (100µg/ml, Invitrogen). When specified, paraformaldehyde 479 
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(PFA)-killed (PFA 4%, 20 minutes) or heat-killed (95°C, 15 minutes) of P. aeruginosa 480 
strains were used to infect BMDMs at MOI of 50. When required, Shigella flexneri (M90T), 481 
Chromobacter violaceum or various Salmonella strains (SL1344) were grown in LB in the 482 
presence or absence of antibiotics (specified in the resource table) at 37°C with constant 483 
agitation overnight. To ensure proper T3SS and flagellin expression, bacteria were sub-484 
cultured the next day in LB media for 3 h until reaching an OD of 0,6-1. 485 
When required, Flagellin was electroporated with Neon™ Transfection System 486 
(ThermoFischer) according manufacturer’s protocol. Briefly, 5 x 105 cells were 487 
resuspended in Buffer R and 0.5 ug/ml Flagellin was electroporated in 10 μl tips using 2 488 
pulses of 1720V and 10 width. Cells were then plated in 24 well-plates. 489 
Transfection of cells with Fagellin (Invivogen, 0, 5µg/mL/2,5x105 cells) or LPS (O111:B4, 490 
E. coli, 1µg/2,5x105 cells Invivogen) was achieved using FuGeneHD (Promega) 491 
transfection reagent in Opti‐MEM culture medium (44). 492 
 493 
Bone marrow Neutrophil isolation 494 
Neutrophils were isolated from bone-marrow cells of WT mice by positive selection using 495 
Anti-Ly6G MicroBeads UltraPure isolation kit (Miltenyi-Biotec, Anti-Ly6G MicroBeads 496 
UltraPure mouse) according to the manufacturer’s instructions. Characterization of the 497 
purified population by Fluorescence Associated Cell Sorting showed an enrichment of 498 
more than 98% of Ly6Ghigh cells. 499 
 500 
Cytokine and pyroptosis measurement  501 
IL-1β (eBioscience) was measured by ELISA. Cell-death was assayed using LDH 502 
Cytotoxicity Detection Kit (Takara). To normalize for spontaneous lysis, the percentage of 503 
LDH release was calculated as follows: (LDH infected – LDH uninfected)/(LDH total lysis – 504 
LDH uninfected)*100. 505 
 506 
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Western blotting 507 
Cell and supernatant protein lysates were prepared as previously described. Antibodies 508 
used were mouse anti-mouse caspase-1 antibody (Casper, Addipogen), goat anti-mouse 509 
IL-1β antibody (AF-401-NA; R&D Systems), anti-β-actin antibody (A1978; Sigma), anti-510 
GAPDH (GTX100118; GeneTex), anti gasdermin-D (Abcam, ab209845), anti-caspase-11 511 
(Novus, NB120-10454), anti-NLRC4 (Abcam, ab201792) and anti-NLRP3  (AdipoGen, AG-512 
20B-0014). After incubation with primary antibody the membrane was washed 3 times with 513 
TTBS, and then Immunoreactive bands were detected by incubation for 2 h with the 514 
appropriate secondary antibodies conjugated with horseradish peroxidase (Diagomics). 515 
Proteins of interest were visualized using ECL substrate (Biorad) and images were 516 
acquired using ChemiDoc Imaging System (Biorad). Working dilutions of the antibodies 517 
are listed in table 1. 518 
 519 
Intracellular CFU experiments 520 
2.5x105 BMDMs were infected with various PAO1 strains at indicated MOIs for 521 
various times. For CFU assays after 24 hours stimulation, gentamicin protection assay 522 
was performed using gentamicin at 50µg/mL after 2 hours infections of macrophages. 523 
Supernatants were removed, and cells washed 5 times with PBS. Cells were then lysed in 524 
triton x-100 (Sigma), 0.1% and plated at 37°C overnight for CFUs numeration on LB-agar.  525 
 526 
Microscopy 527 
2.5x105 BMDMs were seeded on glass coverslips and infected as described above. 528 
When desired, wells were washed three times with PBS and fixed with 4% PFA for 10 529 
minutes at 37°C. Excess of PFA was removed by PBS washes and quenching using 0,1M 530 
Glycine for 10 min at room temperature. Permeabilization and primary antibody staining 531 
were performed O/N at 4°C using Saponin 0.1%/BSA 3% solution. Stainings were 532 
performed using Hoescht (DNA labeling), rabbit anti-ASC (SCBT, 1/500), chicken anti-533 
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P.aeruginosa LPS (1/500, Agrisera) or anti-CD45-2-APC (1/250, Biolegends). Coverslips 534 
were washed with Saponin/BSA solution and incubated with the appropriate secondary 535 
antibodies (1/500, Diagomics). Cells were then washed 3 times with PBS and mounted on 536 
glass slides using Vectashield (Vectalabs). Coverslips were imaged using confocal Zeiss 537 
LSM 710 (Image Core facility, Biozentrum, Basel and CPTP, Toulouse) or an 538 
Olympus/Andor CSU-X1 Spinning disk microscope (Image core Facility, IPBS, Toulouse) 539 
using a 63x objective. Unless specified, for each experiment, 5-10 fields (∼50-250 cells) 540 
were manually counted using Image J software. 541 
 542 
Time-lapse microscopy 543 
5x105 iBMDMs Gal3-morange expressing cells were seeded in a 35 mm microdish 544 
(Ibidi). 1 hour before infection, cells were pre-stained with 0.1 µM CSFE (Biolegend) and 545 
infected with T3SS+ or T3SS- P. aeruginosa with a MOI of 25 or 50. 1µM of membrane 546 
impermeant fluorescent DNA binding probe TO-PRO®-3 (ThermoFisher) was also added 547 
to the culture medium. Live cell imaging was performed using an Olympus/Andor CSU-X1 548 
spinning disk microscope  with a picture frequency of 5 minutes for 3-4 hours and videos 549 
were reconstructed using Image J software. 550 
 551 
PIT experiments 552 
We have set up a modified form of a published protocol (13). Unless otherwise 553 
specified, WT BMDMs were infected using an MOI of 50 PAO1 T3SS+ or T3SS- for 3 h. 554 
Intracellular bacteria-associated to PITs were visualized and manually quantified by 555 
microscopy (Olympus/Andor CSU-X1 spinning disk or inverted confocal microscope Zeiss 556 
LSM 710, ∼50 cells counted, 5-10 fields). For bacterial colony forming units snumber 557 
enumeration, cells were lysed in Triton X-100, 0.1% and plated on Luria Broth agar.  558 
 559 
 560 
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Bacterial response to a secondary stress signal 561 
A modified version of published protocol was used (13). WT BMDMs were infected 562 
for 2 h with PAO1 T3SS+ or T3SS- using MOI of 50. Then, both extracellular and PIT-563 
associated bacteria were harvested. As intracellular bacteria recovery required cell lysis 564 
with TritonX-100 0.1%, extracellular bacteria were also incubated with TritonX-100 0.1% 565 
for 2 minutes. When specified, bacteria from cells and supernatants were added to 1mL 566 
LB supplemented with 50µM Hydrogen Peroxide (H202) or PBS for 45 minutes, at 37°C 567 
and then plated on LB agar plates.  568 
For neutrophil killing assays, WT BMDMs (2.5x105 cells) were infected for 2 h with 569 
PAO1 T3SS+ or T3SS- using MOI of 50. Both supernatant- and bacteria-containing PITs 570 
were exposed to neutrophils (1x106 cells) for 1.5 h. Then, cells were treated with Triton X-571 
100 0.1% for 2 minutes, and CFU counts were enumerated on LB agar plates. 572 
 573 
ImageStreamX experiments 574 
WT mice (n=3 for each bacterial strain) were infected intraperitonealy with 3x106 CFUs in 575 
PBS (100µL/mouse) of either T3SS+ or T3SS- GFP-expressing bacteria. 4 hours later, 576 
peritoneal lavages were collected in 2,5mL of PBS. Neutrophils were stained prior to 577 
fixation with anti-Ly6G (APC-Vio770, Miltenyi-Biotec Clone: REA526 | Dilution: 1:50). 578 
Then, cells were fixed and permeabilized with BD Fixation/Permeabilisation Kit according 579 
to the manufacturer’s instructions, and macrophages were labeled with anti-F4/80 (BV421) 580 
(Biolegend Clone: BM8 | Dilution: 1:100). Data were acquired on ImageStreamXMKII 581 
(Amnis) device (CPTP Imaging and Cytometry core facility) and analyzed using IDEAS 582 
software v2.6 (Amnis). The gating strategy used to evaluate efferocytosis of bacteria-583 
containing macrophages by Neutrophils was performed as follows: (i) gate was set on cells 584 
in focus and (ii) sub-gated on single cells. Then, we gated both on (iii) Ly6G+ Neutrophils 585 
and on (iv) F4/80+ macrophages within Ly6G+ population. (v) To distinguish efferocytosis 586 
of intact from fragmented macrophages, we created a mask based on the Surface Area of 587 
.CC-BY-NC-ND 4.0 International licensenot certified by peer review) is the author/funder. It is made available under a
The copyright holder for this preprint (which wasthis version posted May 28, 2019. . https://doi.org/10.1101/650333doi: bioRxiv preprint 
23 
 
F4/80+ signal. This was applied to Ly6G+/F4/80+ gate. (vi) The percentage of GFP+ 588 
bacteria within the Ly6G+/F4/80+ population was visualized and quantified. 589 
 590 
Bacterial KO generation and complementation 591 
The knockout vector pEXG2 was constructed and used based on the protocol 592 
described by Rietsch et al. (45) with the following modifications. Briefly, 700-bp sequences 593 
of the flanking regions of the selected gene were amplified by PCR with Q5 high fidelity 594 
polymerase (New England Biolabs). Then, the flanking regions were gel purified and 595 
inserted into pEXG2 plasmid by Gibson assembly (46). The assembled plasmid was 596 
directly transformed into competent SM10λpir using Mix&Go competent cells (Zymo 597 
Research Corporation) and plated on selective LB plates containing 50 µg/mL kanamycin 598 
and 15 µg/mL gentamicin. The resulting clones were sequenced, and mating was allowed 599 
for 4 h with PAO1 strain at 37°C. The mated strains were selected for single cross over on 600 
plates containing 15 µg/mL gentamicin and 20 µg/mL Irgasan (removal of E.coli SM10 601 
strains). The next day, some clones were grown in LB for 4 hours and streaked on 5% 602 
sucrose LB plates overnight at 30°C. P. aeruginosa clones were then checked by PCR for 603 
mutations. For flagellin complementation experiments, JBOC plasmid (homemade) was 604 
used to re-express flagellin gene (fliC) under its endogenous promoter in fliC deficient 605 
PAO1 strains. Briefly, PAO1 fliC and its promoter were PCR-amplified, purified and 606 
integrated in JBOC plasmid. SM10 E.coli were transformed with fliC plasmid and allowed 607 
to conjugate with PAO1 mutant strains as described above. Positive PAO1 strains were 608 
selected on Gentamicin-Irgasan plates and checked by subsequent PCRs. All primers 609 
were designed with Snapgene software (GSL Biotech LLC). 610 
 611 
Statistical analysis 612 
Statistical data analysis was performed using Prism 5.0a (GraphPad Software, 613 
Inc.). For comparison of two groups (cell death, cytokine secretion, CFU and microscopy-614 
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based counts), we used two-tailed t-test. Bonferroni correction was applied for multiple 615 
comparisons to two-way ANOVA statistical analysis. Data are reported as mean with 616 
standard deviation (s.d). For animal experiments Mann-Whitney tests were performed. P 617 
values are given in figures, NS means non-significant, unless otherwise specified. 618 
Significance is specified as *, ** or *** for P-values <0.05, <0.01 or <0.001 respectively. 619 
 620 
Data and software 621 
Fiji and Image J software was used for time-lapse and microscopy images 622 
processing and analysis. Snapgene software (GSL Biotech LLC) was used to design all 623 
primers. Cytometry data analysis and processing were performed using FlowJo.10 624 
software. ImageStreamX data were analyzed using IDEAS software v2.6 (Amnis). 625 
Benchling online software was used to design Crispr guides. 626 
 627 
Ethics Statement 628 
All animal experiments were approved (License 2535, Kantonales Veterinäramt Basel-629 
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ethical laws) and the European Union animal protection directive (Directive 2010/63/EU). 632 
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Figures & legends  829 
 830 
 831 
Fig. 1: Efficient pyroptosis-induced PIT response in macrophages depends on 832 
bacterial localization.  833 
BMDMs were primed with 100 ng/mL of the TLR2 ligand Pam3CSK4 for 16 h to induce pro-834 
IL-1β expression and then infected with S. Typhimurium and P. aeruginosa for various 835 
times. 836 
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(A) Measurement of LDH and IL-1β release in WT and Nlrc4–/– BMDMs infected for 3 h 837 
with PAO1 and S. Typhimurium at an MOI of 15. 838 
(B) Phagocytosis scoring of WT or Nlrc4–/– BMDMs infected for 1 hour with PAO1 and S. 839 
Typhimurium at an MOI of 15.  840 
(C) CFU evaluation of Nlrc4–/– BMDMs infected for various time (1-24h) with PAO1 and S. 841 
Typhimurium at an MOI of 15. 842 
(D) Cell death (LDH) and IL-1β release evaluation in WT BMDMs, pre-incubated or not 843 
with cytochalasin D (0.2µg/mL) for 30 minutes, and then infected with either P. aeruginosa, 844 
S. Typhimurium (MOI 15). 845 
(E, F) Microscopy illustrations and quantifications of PIT (ASC+ cells)-associated P. 846 
aeruginosa and S. Typhimurium in WT BMDMs infected for 1H with an MOI 3.  847 
Graphs show mean and s.d of quadruplicate wells (A and D) from three independent 848 
experiments pooled together. CFUs scoring are representative of one experiment 849 
performed 5 times. 850 
Regarding microscopy quantification (E, F), 10 fields containing approximately 200 cells 851 
were quantified using the Image J software. 852 
 853 
  854 
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 855 
Fig. 2: T3SS- P. aeruginosa activate both NLRC4 and Caspase11 inflammasomes.  856 
PAM3CSK4-primed (100 ng/mL) BMDMs were infected for various times with bacterial 857 
strains PAO1 T3SS+, T3SS- or T3SS-/fliC- at an MOI of 25, unless otherwise stated. 858 
(A) Kinetics of IL-1β released by immortalized WT, Nlrc4–/– or Nlrc4–/–/Casp11–/– BMDMs 859 
infected with PAO1 T3SS- or T3SS-/fliC-.  860 
(B) Western blot examination of processed caspase-1 (p20) and gasdermin-D (p30) in 861 
supernatants and pro-caspase-1 (p45), pro-gasdermin-D (p55), NLRP3, NLRC4 and 862 
GAPDH in cell lysates of WT, Nlrc4–/–, Nlrp3–/– and Nlrc4–/–/Nlrp3–/– BMDMs infected for 3 863 
h with PAO1 T3SS+, T3SS- or T3SS-/fliC-. 864 
(C) Measurement of LDH and IL-1β release from WT, Naip5–/– or NaipΔ1-6 BMDMs infected 865 
for 3 h with PAO1 T3SS+ or T3SS-.  866 
Graphs show mean and s.d of quadruplicate wells (A, C) pooled from three independent 867 
experiments.  Immunoblotting (B) is representative of one experiment performed two 868 
times.  869 
 870 
 871 
 872 
 873 
.CC-BY-NC-ND 4.0 International licensenot certified by peer review) is the author/funder. It is made available under a
The copyright holder for this preprint (which wasthis version posted May 28, 2019. . https://doi.org/10.1101/650333doi: bioRxiv preprint 
35 
 
 874 
Fig. 3: T3SS- P. aeruginosa associate to damaged phagosomes to promote 875 
inflammasome response.  876 
PAM3CSK4-primed BMDMs were infected with various Pseudomonas aeruginosa strains 877 
at an MOI of 25, unless specified. 878 
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(A) LDH and IL-1β released by WT and Nlrc4–/– BMDMs, pre-incubated or not with 879 
cytochalasin D (0.2µg/mL) for 30 minutes, and then infected for 3 h with PAO1 T3SS+ or 880 
T3SS-. 881 
(B) Western blot analysis of cleaved CASP1 (p20) in cell supernatants and of pro-CASP1 882 
and β-actin in cell extracts of WT and Casp1–/–/11–/– BMDMs infected for 3 h with T3SS+ or 883 
T3SS- PAO1. 884 
(C) LDH and IL-1β release in WT, Nlrc4–/– or Casp11–/– BMDMs, pre-incubated or not with 885 
cytochalasin D (0.2µg/mL) for 30 minutes, and then infected for 10 h with PAO1 T3SS+, 886 
(D, E) Fluorescence microscopy observations and quantifications of galectin-3 targeted 887 
PAO1 T3SS- or T3SS-/fliC- (MOI 25, 3 hours infection) in Casp-1–/–/11–/– immortalized 888 
BMDMs transduced with galectin-3-morange.  889 
(F, G) Observations and quantifications of FAM-VAD-FMK FLICA probe recruitment on 890 
GAL-3-mOrange+ Pseudomonas aeruginosa (T3SS-) in IFNγ-primed immortalized (i) 891 
iNlrc4–/–/GAL3-morange and iNlrc4–/–/Casp11–/–/GAL3-mOrange BMDMs 3 h after 892 
infection. Caspase-11 is in green, galectin-3 in red, bacteria in grey and nuclei in blue. 893 
Graphs show mean and s.d. (A, C) represent pooled data from at least three independent 894 
experiments performed in quadruplicate. (B) is representive of one experiment performed 895 
in duplicate. (D, F) Microscopy quantification of 10 fields containing approximately 200 896 
cells performed using the Image J software.  897 
 898 
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 899 
Fig. 4: Pyroptosis-induced P. aeruginosa entrapment and elimination is mostly 900 
efficient against T3SS-deficient bacteria.  901 
Unprimed BMDMs were infected with various Pseudomonas aeruginosa strains at an MOI 902 
of 25, unless otherwise specified. 903 
(A,B) Microscopy illustrations and quantifications of PIT (ASC+ cells)-associated P. 904 
aeruginosa T3SS+ or T3SS- in WT BMDMs infected for 3h.  905 
(C) Bacterial weakness induced by pyroptosis evaluated by LB agar plating of intracellular 906 
and extracellular PAO1 T3SS+ and T3SS- from WT infected BMDMs after PBS or 907 
neutrophil exposure (1 h 30). 908 
(D) CFU scoring of WT or Nlrc4–/– BMDMs infected for 1 hour with PAO1 T3SS+ or T3SS- 909 
at an MOI of 25. 910 
(E) Bacterial weakness induced by pyroptosis (ATP, 5 mM, 2 h) evaluated by LB agar 911 
plating of intracellular P. aeruginosa T3SS+ and T3SS- (MOI 25, 1h) from Nlrc4–/– infected 912 
BMDMs after PBS or H2O2 exposure (50 µM).  913 
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(F) ImagestreamX quantification of the % of (i) Neutrophils (Ly6G+)/macrophage (F4/80+) 914 
and, (ii) Neutrophils (Ly6G+)/macrophages (F4/80+)/bacteria (GFP+) in the peritoneal cavity 915 
of WT mice infected for 4 h with 3.106 CFUs of T3SS+ or T3SS- P. aeruginosa. Single dots 916 
are representative of each individual mouse infected with either strain of P. aeruginosa. 917 
Images represent the acquisition of more than 100 000 total events. Upper image panel 918 
and lower image panel show representatives images from the Neutrophils 919 
(Ly6G+)/macrophages (F4/80+) gate obtained from mice infected with T3SS+ or T3SS- P. 920 
aeruginosa respectively. Here, three independent experiments were conducted. 921 
All data (A-F) are expressed as mean and s.d. Data are representative of three 922 
independent experiments.  923 
 924 
Movie 1 shows T3SS+ PAO1 mcherry entrapment into dead cells and refers to Fig. 4. 925 
Movie 2 shows T3SS- PAO1 mcherry entrapment into dead cells and refers to Fig. 4. 926 
 927 
 928 
 929 
 930 
 931 
 932 
 933 
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 934 
Fig. 5: Both NLRC4 and Caspase-11 only protect against acute infection with T3SS-935 
deficient P. aeruginosa. 936 
(A, C) BALF PAO1 CFU scoring after 18 h of WT, Nlrc4–/– (A) or Casp11–/– (C) mice 937 
infected with either T3SS+ or T3SS-  P. aeruginosa strains at 5x106 (T3SS+) and 1.5x107 938 
(T3SS-) CFUs respectively. 939 
(B, D) BALF IL-1β release assay in mice infected as described in (A, C).  940 
(E, F) Role of alveolar macrophages on the immune response to PAO1. (E) PAO1 CFUs 941 
scoring in BALFs after 18 h of infection with either the T3SS+ or T3SS- P. aeruginosa 942 
strains in control or clodronate treated mice as in (A, C).  (F) IL-1β release in BALFs of 943 
control or clodronate treated mice infected with either the PAO1 T3SS+ or T3SS- strains as 944 
in (B, D).  945 
All data are representative results of 2 (C-F) and 3 (A, B) independent experiments. 946 
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Supplementary information 947 
 948 
Figure S1:  Pseudomonas aeruginosa T3SS promotes phagocytosis-independent 949 
activation of the NLRC4 inflammasome. 950 
BMDMs were primed with 100 ng/mL of the TLR2 ligand Pam3CSK4 for 16 h to induce pro-951 
IL-1β expression and then infected for 3 hours (h) with various bacteria (MOI 15) or 952 
inflammasome inducers. 953 
(A) Measurement of cell death (LDH release) from WT and Nlrc4–/– BMDMs after 3 h of 954 
infection with either T3SS+ or T3SS- PAO1 or STm. 955 
(B) CFU scoring in WT and Nlrc4–/– BMDMs infected for 1h with either PAO1 or STY-956 
deficient P. aeruginosa. 957 
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(C) LDH and IL-1β release quantifications of WT and Nlrc4–/– BMDMs infected for 3 h with 958 
either PAO1 or STY-deficient P. aeruginosa in presence or not of Cytochalasin D (0,2 959 
µg/mL). 960 
(D) LDH release quantifications of WT and Nlrc4–/– BMDMs, pretreated or not with 961 
Cytochalasin D (0,2 µg/mL), electropororated (Neon™ Transfection System)  with 0.5 962 
ug/ml and then plated for 1 h. 963 
(E) LDH and IL-1β released by WT BMDMs, pre-incubated or not with cytochalasin D 964 
(0.2µg/mL) for 30 minutes, and then infected with either P. aeruginosa, S. Typhimurium, S. 965 
flexneri or C. violaceum. 966 
(F) CFU scoring in the peritoneal cavity of WT and GsdmD–/– mice infected for 6 h with 967 
3.106 CFUs of P. aeruginosa and S. Typhimurium.  968 
All graphs (A-E) show mean and s.d of quadruplicate wells from three pooled experiments. 969 
(F) represents one experiment from three independent experiments. 970 
 971 
 972 
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 973 
Figure S2: P. aeruginosa triggers T3SS-independent activation of both NLRC4 and 974 
Caspase11 inflammasomes.  975 
(A, B) Biochemical (A) and functional (B) characterization of two iCas9Nlrc4–/–/sgCasp11–976 
/– CRISPR KO clones. (B), LDH release measurement of CRISPR clones (A) transfected 977 
with either 0,5 µg/mL of Flagellin (2 hours) or 5µg/mL of LPS (10 hours).   978 
(C) Cell death evaluation (LDH) in WT and Nlrc4–/– BMDMs infected with various MOIs of 979 
PAO1 T3SS+ or T3SS- for 3 h.  980 
(D, E) LDH measurement in  WT and Nlrc4–/– BMDMs infected by PAO1 T3SS+, T3SS- or 981 
T3SS-/fliC-, complemented or not for flagellin expression (fliC-:: fliC) for 3h with an MOI of 982 
50. 983 
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(F) Measurement of IL-1β release from WT and Nlrc4–/– BMDMs after 3 h of infection with 984 
live, PFA-killed or heat killed (HK) T3SS deficient-PAO1 at an MOI of 50. 985 
(G) Measurement of LDH and IL-1β release from WT, Nlrc4–/– and Casp1–/–/11–/– BMDMs 986 
after 3 h of infection with T3SS deficient-PAO1 exsA- or -PAO1 pscC- at an MOI of 50. 987 
Graphs show mean and s.d of quadruplicate wells pooled from three independent 988 
experiments.   989 
 990 
 991 
Figure S3: T3SS- P. aeruginosa associate to altered phagosomes.  992 
(A) Biochemical characterization of two iCas9Nlrc4–/–/sgCasp11–/– CRISPR KO clones. 993 
(B) Fluorescence microscopy observations and quantifications of galectin-3 targeted 994 
PAO1 T3SS- (MOI 25, 3 h of infection) in iWT and iCasp1–/–/11–/–/sgNlrc4–/– BMDMs 995 
transduced with galectin-3-morange.  996 
Graphs show mean and s.d of quadruplicate wells from three independent pooled 997 
experiments.  Immunoblotting representative of one experiment performed on various 998 
clones. Microscopy analysis visualized 10 fields containing approximately 200 cells using 999 
Image J software. 1000 
 1001 
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 1002 
Figure S4: ImagestreamX gating strategy used. 1003 
(A) ImagestreamX gating strategy used to visualize and quantify neutrophil-mediated 1004 
efferocytosis of bacteria-containing macrophages. 1005 
(i) A gate was set on cells in focus [Cells in Focus], then (ii) single cells [Single Cells] were 1006 
gated. (iii) First, gate was put on Ly6G+ Neutrophils [Ly6G+] and then we selected (iv) 1007 
F4/80+ macrophages [F4/80+] within Ly6G+ population. (v) A mask based on the surface 1008 
Area of F4/80+ signal was applied to Ly6G+/F4/80+ gate to discriminate efferocytosis of 1009 
intact macrophages from fragmented macrophages. As a control, dotted gray line shows 1010 
surface area of F4/80+ signal in the [Ly6G-] gate. Then, (vi) we gated on [F4/80+ low Area] 1011 
and measured the intensity of the GFP signal. Red and Blue lines show the intensity of 1012 
GFP signal measured in mice challenged with either P. aeruginosa T3SS+ or T3SS- strains 1013 
respectively. Finally, GFP+ bacteria percentage within the gate (vi) was visualized. Upper 1014 
image panel and lower image panel show representative images from the Neutrophils 1015 
(Ly6G+)/macrophages (F4/80+) gate obtained in GFP- gate or GFP+ gate respectively. 1016 
 1017 
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 1018 
Figure S5: NLRC4 and Caspase-11 only protect mice against T3SS-deficient P. 1019 
aeruginosa. 1020 
(A-D) PAO1 CFUs scoring and IL-1β levels in BALFs from WT, Nlrc4–/– (A, B) or Casp11–/– 1021 
(C, D) mice after 18 h of infection with T3SS-/fliC- P. aeruginosa strain with 1.5x107 CFUs. 1022 
(E) FACS representation and quantification of depleted alveolar macrophages (F4/F80+, 1023 
CD11c+) in control (PBS) and clodronate instilled mice.  1024 
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 1025 
Graphical abstract. 1026 
Macrophages infected with T3SS-expressing P. aeruginosa die in a NLRC4-dependent 1027 
manner, which allows bacterial escape from PIT-mediated cell-autonomous immunity and 1028 
neutrophil efferocytosis. However, T3SS-deficient P. aeruginosa is detected by both 1029 
NLRC4 and caspase-11 inflammasomes, which promotes bacterial trapping and 1030 
subsequent efferocytosis of P. aeruginosa-containing-PITs by neutrophils. 1031 
 1032 
 1033 
 1034 
 1035 
 1036 
 1037 
 1038 
 1039 
 1040 
 1041 
 1042 
 1043 
 1044 
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Table S1: All products, software and biological samples used in the current study, 1045 
including their references and concentrations, are listed in table 1. 1046 
Reagent  Provider Reference 
Antibodies 
Mouse anti-mouse caspase-1 1/4000 WB Adipogen AG20B-0042 
Rabbit anti-IL-18  1/2500 WB Biovision 5180R-100 
Goat anti-mouse IL-1β 1/1000 WB R&D AF-401-NA 
Rabbit anti-mouse Gasdemin D 1/1000 WB Abcam ab209845 
Rat anti-mouse Caspase-11 (17D9) 1/1000 
WB 
Novus NB120-10454 
Rabbit anti-mouse Nlrc4 1/1000 WB Abcam ab201792 
Mouse anti-mouse NLRP3 1/1000 WB AdipoGen AG-20B-0014 
Mouse anti-β-actin 1/10000 WB Sigma A1978 
Rabbit anti-GAPDH 1/10000 WB GeneTex GTX100118 
Rabbit anti-ASC 1/1000 IF SantaCruz Sc-22514-R 
Chicken anti-Pseudomonas LPS 1/5000 IF Agrisera IMS01-133-332 
Anti-CD45-2-APC IF Biolegends 109818 
Anti-CD19-PE-Cf594 0.2µg/mL FACS  Biolegends 115554 
Anti-TCRβ-APC-Cy7 0.2µg/mL FACS Biolegends 109220 
Anti-F4/80-BV421 50µg/mL FACS Biolegends 123132 
Anti-CD11b-PE-Cy7 0.2µg/mL FACS Biolegends 101216 
Anti-CD11c-A488 0.5µg/mL FACS Biolegends 117311 
Anti-Ly6C-PercpC5 0.2µg/mL FACS Biolegends 128012 
Anti-MHCII-PE 0.2µg/mL FACS Biolegends 107608 
Anti-CD86-BV510 50µg/mL FACS Biolegends 105039 
Anti-Ly6G-A647 0.5µg/mL FACS Biolegends 127610 
Brilliant Violet 421™ anti-mouse F4/80 
Antibody 
Biolegends 123131 
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anti-LY6G (APC-Vio770) Miltenyi-Biotech 130-107-916 
   
Sec antibodies   
Goat anti-Rat IgG (H&L) DyLight 488  IF 1/20 
1/2000 IF  
Diagomics GtxRt-003-
D488NHSX 
Chicken anti-Goat IgG (H&L) DyLight 488  
1/500 IF 
Diagomics CkxGt-003-
D488NHSX 
Goat anti-Mouse IgG (H&L) DyLight 488 
1/500 IF  
Diagomics GtxMu-003-
D488NHSX 
Goat anti-Rabbit IgG (H&L) DyLight 488 
1/500  IF  
Diagomics GtxRb-003-
D488NHSX 
Donkey anti-Rabbit IgG (H&L) DyLight 550 
1/500 IF  
Diagomics DkxRb-003-
D550NHSX 
Goat anti-Rat IgG (H&L) DyLight 550 1/500 
IF  
Diagomics GtxRt-003- 
D550NHSX 
Donkey anti-Goat IgG (H&L) DyLight 550 
1/500 IF  
Diagomics DkxGt-003- 
D550NHSX 
Goat anti-Mouse IgG (H&L) DyLight 550 
1/500 IF  
Diagomics GtxMu-003- 
D550NHSX 
Goat anti-Chicken IgG (H&L) DyLight 405 
1/500 IF  
Diagomics GtxCk-003-
D405NHSX 
Goat anti-Rabbit IgG (H&L) DyLight 633 
1/500 IF  
Diagomics GtxRb-003-
D633NHSX 
Goat anti-Rat IgG H&L) DyLight 633 1/500 IF  Diagomics GtxRt-003-
D633NHSX 
Hoescht Sigma H6024 
Rabbit anti-Goat IgG (H&L) HRP Conjugate 
1/3000 
Diagomics RbxGt-003-
DHRPX 
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Rabbit anti-Mouse IgG (H&L) HRP Conjugate 
1/3000 
Diagomics RbxMu-003-
DHRPX 
Goat-anti-mouse IgG (H+L) HRP conjugate 
1/3000 
Diagomics R-05071-500 
Goat-anti-rabbit IgG (H+L) HRP conjugate 
1/3000 
Diagomics R-05072-500 
Goat-anti-rat IgG (H+L) HRP conjugate 
1/3000 
Diagomics R-05075-500 
CSFE Biolegend 423801 
TO-PRO®-3 Iodide (1/10000) Thermo Fischer 
Scientific 
T3605 
 
   
Bacterial and Virus Strains  
PAO1 (47)  
PAO1 ΔexsA (referred as T3SS-) This study N.A 
PAO1 ΔpscC This study N.A 
PAO1 ΔexsA, ΔfliC This study N.A 
PAO1 ΔfliC (fliC-) This study N.A 
PAO1 ΔfliC::fliC This study N.A 
PAO1 ΔexsA, ΔfliC::fliC This study N.A 
PAO1 mCherry This study N.A 
PAO1 ΔexsA mCherry (referred as T3SS-) This study N.A 
PAO1 GFP This study N.A 
PAO1 ΔexsA GFP (referred as T3SS-) This study N.A 
STm SL1344 (orgA-/ssaV-), TetR/KmR 
(grown in LB supplemented with 10µg/ml Tet 
and 50µg/ml Kan)  
(41, 42, 48) N.A 
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STm SL1344 orgA- flAG/B- fliC-, 
TetR/CmR/KmR 
(grown in LB supplemented with 10µg/ml Tet, 
25µg/ml Cm and 50µg/ml Kan) 
(41, 42, 48) N.A 
E. coli Stbl4 Thermo Fisher N.A 
E coli Sm10 Conjugative 
strains 
(Kanamycin) KmR 
N.A 
Biological Samples   
Chemicals, Peptides, and Recombinant Proteins 
FCS Fisher Scientific 16010-159 
MCSF L929 cell 
supernatant 
NA 
HEPES Fisher Scientific SH30237.01 
Non-essential amino acids Invitrogen  
PAM3CSK4 Invivogen tlrl-pms 
 
LPS-EB ULTRAPURE 
 
Invivogen tlrl-3pelps 
 
ATP (NLRP3 inflammasome inducer) invivogen 
 
tlrl-atp 
 
Gentamycin Invitrogen 15710-049 
 
Kanamycin Sigma 60615-5G 
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Irgasan Sigma 72779-25G 
 
LS Columns 
 
Miltenyi Biotec 130-042-401 
Anti-Ly-6G MicroBeads 
UltraPure 
mouse 
Miltenyi Biotec 30-120-337 
BD Fixation/Permeabilisation Kit BD 554714 
WB reagents   
ECL Clarity Max Substrate BioRad 1705060 
ECL Clarity Max Substrate BioRad 1705062 
Western Blot Strip Buffer Diagomics R-03722-D50 
Tris base 
 
euromedex 200923-A 
 
SDS ultra-pure (4x) 
 
Euromedex 
 
1012 
 
Acrylamide / Bisacrylamide 37.5/1 30% Euromedex EU0088-B 
 
Temed 
 
Sigma 
 
T9281-25ML 
 
Ammonium persulfate 
 
Sigma 248614-100g 
 
248614-100g 
 
Page Ruler 10-180 kDa Fisher Scientific 15744052 
Vectashield Vectalabs H-1000 
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Triton X-100 Euromedex 2000 
Hydrogen Peroxide Sigma 21763-500ml 
DMEM Fisher Scientific 41965-039 
 
LB Fisher Scientific BP1426-2 
LB Agar INVITROGEN 22700025 
Cytochalasin D (0.2µg/mL) Sigma C8273-1Mg 
 
Roche protease inhibitor cocktail Sigma 0000000116974
98001 
Saponin Bio Basic canada 
 
SB4521 
 
BSA Sigma A9647-100G 
 
Sucrose Sigma S7903 
Clodronate Liposomes Liposoma 283539 
   
Critical Commercial Assays 
IL-1β ELISA kit ebiosciences 12354003 
LDH Cytotoxicity Detection Kit Takara MK401 
FAM-VAD-FMK FLICA Poly Caspase Assay BioRad ICT091 
Neutrophil Isolation Columns MACS Miltenyi 
Biotech 
130-097-658 
Experimental Models: Cell Lines 
Naip5-/- BMDMs R.E.Vance N.A 
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Naip1-6-/- BMDMs R.E.Vance N.A 
C57BL/6 J primary BMDMs Janvier N.A 
C57BL/6 N primary BMDMs Charles River N.A 
Immortalized Casp-1-/-/-11-/- BMDMs   This study N.A 
Immortalized GBPChr3-/- BMDMs This study N.A 
Immortalized iCas9 Nlrc4-/- This study N.A 
Immortalized iCas9 Casp-1-/-/-11-/- This study N.A 
Immortalized iCas9 Casp-1-/-/-11-/-/sgNlrc4-/- This study N.A 
Immortalized iCas9 Nlrc4-/-/sgCasp-11-/- This study N.A 
Experimental Models: Organisms/Strains 
C57BL/6 J mice Janvier N.A 
C57BL/6 N mice Charles River N.A 
Nlrc4-/-  and Casp11-/- mice V.M Dixit 
(Genentech) 
N.A 
Nlrp3-/- mice P. Broz (Univ. of 
Lausanne) 
N.A 
Casp-1-/-/-11-/- mice R. Flavell N.A 
Nlrc4-/- mice F. Sutterwala  N.A 
Oligonucleotides 
exsA Rup Fw 
SIGMA: 
ttccacacattatacga
gccggaagcataaat
gtaaagcaagcttGC
TGGCGTTGCTG
CTCGG 
N.A 
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exsA Rup Rv 
SIGMA: 
TACCGGGCTTT
CAAAAAACGAT
TATAAGAACCC
CAACACTTCCC
G 
N.A 
exsA Rdown Fw 
SIGMA: 
AGTGTTGGGGT
TCTTATAATCGT
TTTTTGAAAGC
CCGGTAGC 
N.A 
exsA Rdown Rv 
SIGMA: 
ggaaattaattaaggt
accgaattcgagctcg
agcccggggatccC
GTCTCCAGCTT
GCCG 
N.A 
exsA Rup check 
SIGMA: 
TCGCCGACGGT
GACGGCAC 
N.A 
exsA Rdown check 
SIGMA: 
GAGCAGCGTCG
CCATGCCCC 
N.A 
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fliC Rup Fw 
SIGMA: 
ttccacacattatacga
gccggaagcataaat
gtaaagcaagcttAC
GCTATCCCGCC
TACCT 
N.A 
fliC Rup Rv 
SIGMA: 
GTGAGTGACCG
TTCCCGGGCGG
TGATTTCCTCC
AAAGGACCTAT
TTCG 
N.A 
fliC Rdown Fw 
SIGMA: 
GTCCTTTGGAG
GAAATCACCGC
CCGGGAACGGT
CAC 
N.A 
fliC Rdown Rv 
SIGMA: 
ggaaattaattaaggt
accgaattcgagctcg
agcccggggatccC
GCGCTGATCGC
ACTCT 
N.A 
fliC Rup check 
SIGMA: 
ATTCTGCCCGG
ATGCCTTGC 
N.A 
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fliC Rdown check 
SIGMA: 
CTTCGTTGGAA
GACTTGGCGG 
N.A 
pscC Rup fw 
SIGMA: 
ttccacacattatacga
gccggaagcataaat
gtaaagcaagcttCG
GCTTCGGCACT
GGCGA 
N.A 
pscC Rup Rv 
SIGMA: 
CCATGCTAATT
CCCGCGCTCCA
GCAGGCGGCG
CATCAG 
N.A 
pscC Rdown fw 
SIGMA: 
CCCTGATGCGC
CGCCTGCTGGA
GCGCGGGAATT
AGCATGGCC 
N.A 
pscC Rdown Rv 
SIGMA: 
ggaaattaattaaggt
accgaattcgagctcg
agcccggggatccG
ATGAAATCCAC
GCCCTGGC 
N.A 
pscC Rup check 
SIGMA: 
AGGAACTGGCC
AGGGTCGC 
N.A 
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pscC Rdown check 
SIGMA: 
CCCAGCCAGGC
TTGTCCG 
N.A 
JBOC FliC Fw 
SIGMA: 
agccattcTCAGTG
AAGCATCAAGA
CTAACAAATCct
acgggcgcgcatctcg
agg 
N.A 
JBOC FliC rv 
SIGMA: 
GAAAATCTTCT
CTCATCCGCCA
AAACAGCCAAG
CTAATTCttagcgc
agcaggctcag 
N.A 
Gal-3 up Sigma: 
GATCCTCGAGG
CCGCCACCATG
GTGAGCA 
N.A 
Gal-3 down Sigma: 
GATCGCGGCC
GCTTATATCAT
GGTATATGAAG
CACTG 
N.A 
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Actin  Sigma 
Fw 5’-
agccatgtacgtagcc
atcc-3’  
Rv 5’-
ctctcagctgtggtggt
gaa-3’ 
N.A 
   
Recombinant DNA   
pMSCV-Galectin-3-mOrange  This study  
JBOC-fliC plasmid This study Addgene 
deposit 
number 74611 
pMSCV2.2  R.E. Vance  
LentiGuide-Puro  Feng Zhang lab addgen ref 
52963 
pMD.2G  Didier Trono lab addgene ref 
12259 
p8.91 Didier Trono lab N.A. 
LentiCas9-Blast Feng Zhang lab addgen ref 
52962 
Nlrc4 targetting primer Forward:  Sigma-Aldrich 
5’CACCG-
TTACTGTGAGC
CCTTGGAGC3’ 
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Nlrc4 targetting primer reverse:  Sigma-Aldrich 
5’AAAC-
GCTCCAAGGGC
TCACAGTAA-C3’ 
 
Caspase 11 targetting primer forward  Sigma-Aldrich 
5‘CACCG-
CTTAAGGTGTT
GGAACAGCT3’ 
 
Caspase 11  targetting primer reverse  Sigma-Aldrich 
5’AAAC-
AGCTGTTCCAA
CACCTTAAG-C3’ 
 
Software and Algorithms   
Graph Pad Prism 5.0  N.A 
Image J  N.A 
Snapgene GSL Biotech LLC, 
Chicago, U.S.A 
N.A 
FlowJO  FlowJo LLC N.A 
Fiji (Image J)  N.A 
Benchling Software  N.A 
IDEAS software v2.6  Amnis  
 1047 
Information and requests for reagents may be sent to Etienne Meunier 1048 
(Etienne.meunier@ipbs.fr) or Petr Broz (Petr.broz@unil.ch).  1049 
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